Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker IMTX
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Aaron Cowen | 8.75M | 5.8% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Averill Master Fund, Ltd. | 7.46M | 5.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Montanova Capital, LLC | 8.75M | 5.8% | SCHEDULE 13G/A ↗ |
| Aug 27, 2026 | SCHEDULE 13D/A (amended) | IMTX Immatics N.V. | Joseph Edelman | 11.42M | 7.6% | SCHEDULE 13D/A ↗ |
| Aug 27, 2026 | SCHEDULE 13D/A (amended) | IMTX Immatics N.V. | Perceptive Life Sciences Master Fund, Ltd. | 11.42M | 7.6% | SCHEDULE 13D/A ↗ |
| Aug 27, 2026 | SCHEDULE 13D/A (amended) | IMTX Immatics N.V. | Perceptive Advisors LLC | 11.42M | 7.6% | SCHEDULE 13D/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Felix J. Baker | 9.51M | 7.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Julian C. Baker | 9.51M | 7.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Baker Bros. Advisors (GP) LLC | 9.51M | 7.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Baker Bros. Advisors LP | 9.51M | 7.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | T. Rowe Price Investment Management, Inc. | 21.65M | 16.1% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Roderick Wong | 12.87M | 9.6% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | RTW Investments, LP | 12.87M | 9.6% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G | IMTX Immatics N.V. | The Toronto-Dominion Bank | 7.44M | 5.5% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Ryan Wilder | 6.17M | 4.6% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Vestal Point Capital, LP | 6.17M | 4.6% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Roderick Wong | 11.43M | 8.5% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | RTW Investments, LP | 11.43M | 8.5% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Aaron Cowen | 11.19M | 8.3% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Averill Master Fund, Ltd | 9.55M | 7.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Suvretta Capital Management, LLC | 11.19M | 8.3% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Roderick Wong | 8.82M | 7.3% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | RTW Investments, LP | 8.82M | 7.3% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Felix J. Baker | 12.09M | 9.9% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Julian C. Baker | 12.09M | 9.9% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Baker Bros. Advisors (GP) LLC | 12.09M | 9.9% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Baker Bros. Advisors LP | 12.09M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | T. Rowe Price Investment Management, Inc. | 18.33M | 15.1% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Felix J. Baker | 10.17M | 8.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Julian C. Baker | 10.17M | 8.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Baker Bros. Advisors (GP) LLC | 10.17M | 8.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Baker Bros. Advisors LP | 10.17M | 8.4% | SCHEDULE 13G/A ↗ |
| Aug 13, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Aaron Cowen | 12.03M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 13, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Averill Master Fund, Ltd. | 10.62M | 8.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Suvretta Capital Management, LLC | 12.03M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 12, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Wellington Investment Advisors Holdings LLP | 5.32M | 4.4% | SCHEDULE 13G/A ↗ |
| Aug 12, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Wellington Group Holdings LLP | 5.32M | 4.4% | SCHEDULE 13G/A ↗ |
| Aug 12, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Wellington Management Group LLP | 5.32M | 4.4% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Wellington Management Company LLP | 8.58M | 6.7% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Wellington Investment Advisors Holdings LLP | 8.58M | 7.1% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Wellington Group Holdings LLP | 8.58M | 7.1% | SCHEDULE 13G/A ↗ |
| May 12, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Wellington Management Group LLP | 8.58M | 7.1% | SCHEDULE 13G/A ↗ |
| May 2, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Aaron Cowen | 9.14M | 7.5% | SCHEDULE 13G/A ↗ |
| May 2, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Averill Master Fund, Ltd. | 8.09M | 6.7% | SCHEDULE 13G/A ↗ |
| May 2, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Suvretta Capital Management, LLC | 9.14M | 7.5% | SCHEDULE 13G/A ↗ |
| Mar 7, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | T. Rowe Price Investment Management, Inc. | 14.15M | 11.6% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | T. Rowe Price Investment Management, Inc. | 10.60M | 8.7% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Felix J. Baker | 7.28M | 6.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Julian C. Baker | 7.28M | 6.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | IMTX Immatics N.V. | Baker Bros. Advisors (GP) LLC | 7.28M | 6.0% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances